Home Microsoft CVE-2026-32224
Back to Microsoft

CVE-2026-32224

Windows Server - Windows Server Update Service

Microsoft CVSS 7 Updated April 16, 2026

Executive Risk Summary

"A use-after-free vulnerability in Windows Server Update Service allows an authorized attacker to elevate privileges locally, potentially leading to unauthorized access to sensitive data and system resources. This vulnerability can be exploited by an attacker with valid credentials to gain elevated privileges on the affected system."

Anticipated Attack Path

  1. 1. Initial Exploitation: Authorized attacker exploits the use-after-free vulnerability
  2. 2. Privilege Escalation: Attacker gains elevated privileges on the affected system
  3. 3. Post-Exploitation: Attacker accesses sensitive data and system resources

Am I Vulnerable?

  • Verify the presence of the Windows Server Update Service on the system
  • Check for any suspicious activity related to the Windows Server Update Service
  • Review system logs for any indicators of exploitation

Operational Audit Arsenal

Target Type Service
Target Asset wsuservice
Standard Path Windows Server
PowerShell
# 🛠️ Senior Engineer Universal Audit
# Target: wsuservice (Service)
$Targets = 'wsuservice'
$SearchPaths = @("$env:windir\System32", "$env:ProgramFiles", "${env:ProgramFiles(x86)}")

Get-ChildItem -Path $SearchPaths -Include $Targets -Recurse -ErrorAction SilentlyContinue | 
Select-Object FullName, @{Name="Version";Expression={$_.VersionInfo.ProductVersion}}

Patch Impact Forecast

Reboot Required Likely

Potential disruption to Windows Server Update Service functionality

Internal Work Notes

CVE-2026-32224: Use-after-free vulnerability in Windows Server Update Service allows authorized attacker to elevate privileges locally. Apply patch and verify system functionality.

Technical Intelligence & Operational Utilities • Delivered Weekly

Intelligence Sources

Related Microsoft Threats

Data compiled from NVD, MSRC, and CISA KEV Catalog. Intelligence synthesized via AI. Scripts provided for diagnostic purposes under MIT License.